“Risk of Arterial and Venous Thromboembolic Events with Bevacizumab, an Antibody against Vascular Endothelial Growth Factor A (VEGF-A): A Systematic Review and Meta-Analysis”, GJMR, vol. 20, no. B1, pp. 71–85, Feb. 2020, Accessed: Aug. 13, 2026. [Online]. Available: https://medicalresearchjournal.org/index.php/GJMR/article/view/1952